Arxis, Inc. (ARXS) Stock Price & How to Invest

Arxis, Inc. designs and manufactures specialized engineered components for demanding, mission-critical applications through two segments, Electronic Components (connectors, cable assemblies, RF and microwave products, sensors, and passives) and Mechanical Components (precision manufacturing). Its end markets split roughly across Defense and Space (around 47 percent of 2025 revenue), Commercial Aerospace (around 23 percent), and Industrial Technology (around 30 percent). The company was founded in 2019 out of predecessor businesses (including Quantic and Qnnect), backed by private-equity firm Arcline Investment Management, and is headquartered in Bloomfield, Connecticut with several thousand employees.

Arxis completed its Nasdaq IPO in April 2026 under the ticker ARXS, raising roughly ~$1.22 billion in net proceeds and using around ~$946 million to repay debt, which reset its balance sheet. The investment picture is a high-growth industrial supplier guiding to strong double-digit revenue and adjusted EBITDA growth, priced at a premium that assumes continued execution. Q2 2026 revenue rose about 25% year over year to roughly $501 million and adjusted EPS of $0.28 beat the $0.19 estimate, although GAAP results slipped to a net loss of about $5 million for the quarter after Q1 net income of about $53 million. TTM revenue is about $1.77 billion and TTM net income about $128 million.

Acquisitions have become a large part of the story since the IPO. In August 2026 Arxis closed its purchase of Omnetics Connector, a deal of about $770 million, and in early September it completed acquisitions of Schatz Bearing Corporation and StratEdge Corporation. Debt stood at about $1.79 billion against roughly $495 million of cash in the latest figures. RBC upgraded the stock to Outperform on October 2 with a $60 target, citing growth from M&A and the defense supply chain. As of October 16, 2026 ARXS closed at $54.03, up about 39% year to date and 22% over three months, within a 52-week range of $33.15 to $61.50. Third-quarter results are due October 28, 2026, with consensus EPS of about $0.29 on revenue near $547 million.

As a company that went public only in April 2026, Arxis has a short trading history and limited public track record, which can drive volatility. The stock carries a premium valuation (about 41 times forward earnings and roughly 13 times sales, with a trailing GAAP P/E in the hundreds), so any growth or margin disappointment could compress the multiple. Rapid acquisitions add integration risk and pushed debt back to about $1.79 billion after the IPO paydown, and GAAP earnings turned to a small loss in Q2 2026. Heavy reliance on defense and government-linked spending exposes it to budget cycles, procurement timing, and program delays. Private-equity sponsor ownership means potential future share sales and lock-up expirations could weigh on the stock. Supply-chain and input-cost pressures and customer concentration round out the key concerns.

10 analysts publish price targets on ARXS, averaging $63.70 against a $54.10 price as of October 2026, or +17.7%. The published targets run from $59.00 to $72.00, a narrow spread, and the ratings split 11 buy, 0 hold, 0 sell. Over the last six months there have been 10 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full ARXS forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Arxis, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Defense and space exposure. Nearly half of revenue comes from defense and space programs, which tend to carry long product cycles and steady government-linked demand. The most optimistic published target, $72.00, assumes this works close to its best case.

The case against. As a company that went public only in April 2026, Arxis has a short trading history and limited public track record, which can drive volatility. The most pessimistic target, $59.00, is roughly what ARXS is worth if this bites instead.

Read the full bull and bear case on ARXS, including what would have to change to break either one. Walnut is not an investment adviser.

No. Arxis, Inc. (ARXS) has not split its stock in the last 10 years. That is a statement about the window we check rather than about the company’s entire history, so an older split is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Arxis, Inc.'s investor relations page or your broker.

• Revenue (TTM): ~$1.77B
• Q2 2026 revenue growth: ~25% YoY (~$501M)
• Gross / operating margin (TTM): ~52% / ~7%
• Net income (TTM): ~$128M
• P/E (forward): ~41x (trailing GAAP P/E not meaningful at ~675x)
• Market cap: ~$23.3B
• Cash / debt: ~$495M / ~$1.79B

Arxis trades at about 41 times forward earnings, 13 times sales and roughly 46 times EV/EBITDA, multiples that price in years of acquisition-fueled and organic growth. Analysts expect 2027 EPS of about $1.32, up about 29%, and the 10 analysts Yahoo Finance tracks have a mean target near $64 versus the October 16, 2026 close of $54.03. The October 28 Q3 report, the first with the Omnetics acquisition included for most of a quarter, is the next test.

Other names that sit close to ARXS: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get ARXS exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so ARXS sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where ARXS fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Arxis pairs real defense-and-aerospace revenue and expanding margins with a premium growth valuation (about 41 times forward earnings in October 2026), and since August it has added three acquisitions, including the roughly $770 million Omnetics Connector deal. The story is whether execution and integration keep pace with expectations, starting with Q3 results on October 28, 2026.

Whether ARXS is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is ARXS a buy or a sell?, and where the stock could go from here in the ARXS stock forecast.

For income investors, whether ARXS pays a dividend and how the payout looks is covered in does ARXS pay a dividend? And to weigh ARXS against a peer, read the full side-by-side comparisons: ARXS vs APH and ARXS vs TEL.